Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Respirology (Carlton, Vic.)|November 19, 2016
Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomized control trialsChris D Turnbull, Valentina A Rossi, Peter Santer, et al.Cardiovascular Diabetology|March 22, 2017
Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literatureEllie Paige, Katya L Masconi, Sotirios Tsimikas, et al.Journal of the American College of Cardiology|November 6, 2012
Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular eventsSotirios Tsimikas, Peter Willeit, Johann Willeit, et al.Clinical Chemistry and Laboratory Medicine|July 1, 2015
Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general populationRaimund Pechlaner, Stefan Kiechl, Manuel Mayr, et al.Circulation|May 1, 2004
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular diseaseStefan Kiechl, Georg Schett, Gregor Wenning, et al.Diabetes/Metabolism Research and Reviews|September 18, 2015
Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitusRaimund Pechlaner, Günter Weiss, Sukhvinder Bansal, et al.Circulation|July 11, 2007
Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular diseaseStefan Kiechl, Georg Schett, Judith Schwaiger, et al.Critical Care Medicine|April 16, 2021
Association of Sedation, Coma, and In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome: A Retrospective Cohort StudyKaruna Wongtangman, Peter Santer, Luca J Wachtendorf, et al.Atherosclerosis|December 23, 2008
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general populationStefan Kiechl, Terry Lee, Peter Santer, et al.Journal of the American College of Cardiology|August 30, 2014
Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck StudyPeter Willeit, Stefan Kiechl, Florian Kronenberg, et al.Pageof 7